Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675

Stem Cells

Volumn 33, Issue 12, 2015, Pages 3481-3492

  Huang, Yiping ^a   Zheng, Yunfei ^a   Jia, Lingfei ^a   Li, Weiran ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

H19; lncRNA; Mesenchymal stem cells; miR 675; miRNA; Osteoblast differentiation

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; LENTIVIRUS VECTOR; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 675; RNA H19; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; MIRN675 MICRORNA, HUMAN; SMAD3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EXON; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; UPREGULATION; BONE DEVELOPMENT; CELL DIFFERENTIATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; HISTONE DEACETYLASES; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84983189140     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2225     Document Type: Article

References (50)

1. Pittenger MF, Mackay AM, Beck SC, et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Phinney DG, Prockop DJ,. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-Current views. Stem Cells 2007; 25: 2896-2902.
3. Rastegar F, Shenaq D, Huang J, et al., Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2: 67-80.
4. Macchiarini P, Jungebluth P, Go T, et al., Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372: 2023-2030.
5. Mattick JS,. RNA regulation: A new genetics? Nat Rev Genet 2004; 5: 316-323.
6. Li Z, Hassan MQ, Jafferji M, et al., Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284: 15676-15684.
7. Chen L, Holmstrom K, Qiu W, et al., MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 2014; 32: 902-912.
8. Hwang S, Park SK, Lee HY, et al., miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 2014; 588: 2957-2963.
9. Kureel J, Dixit M, Tyagi AM, et al., miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell Death Dis 2014; 5: e1050.
10. Hung T, Chang HY,. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 2010; 7: 582-585.
11. Li X, Wu Z, Fu X, et al., lncRNAs: Insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res 2014; 762: 1-21.
12. Wang L, Wang Y, Li Z, et al., Differential expression of long noncoding ribonucleic acids during osteogenic differentiation of human bone marrow mesenchymal stem cells. Int Orthop 2015; 39: 1013-1019.
13. Zhang Y, Tycko B,. Monoallelic expression of the human H19 gene. Nat Genet 1992; 1: 40-44.
14. Hurst LD, Smith NG,. Molecular evolutionary evidence that H19 mRNA is functional. Trends Genet 1999; 15: 134-135.
15. Wilusz JE, Sunwoo H, Spector DL,. Long noncoding RNAs: Functional surprises from the RNA world. Genes Dev 2009; 23: 1494-1504.
16. Bartel DP,. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233.
17. Huntzinger E, Izaurralde E,. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99-110.
18. Gabory A, Jammes H, Dandolo L,. The H19 locus: Role of an imprinted non-coding RNA in growth and development. BioEssays 2010; 32: 473-480.
19. Cai X, Cullen BR,. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007; 13: 313-316.
20. Dudek KA, Lafont JE, Martinez-Sanchez A, et al., Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem 2010; 285: 24381-24387.
21. Zhuang W, Ge X, Yang S, et al., Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription. Stem Cells 2015; 33: 1985-1997.
22. Jia LF, Wei SB, Mitchelson K, et al., miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14. PLoS One 2014; 9: e108435.
23. Ge W, Shi L, Zhou Y, et al., Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription. Stem Cells 2011; 29: 1112-1125.
24. Ge W, Liu Y, Chen T, et al., The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1. Biomaterials 2014; 35: 6015-6025.
25. Bhargava U, Bar-Lev M, Bellows CG, et al., Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 1988; 9: 155-163.
26. Wei J, Li H, Wang S, et al., let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev 2014; 23: 1452-1463.
27. Jia LF, Wei SB, Gan YH, et al., Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 2014; 135: 2282-2293.
28. Zhou H, Rigoutsos I,. MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells. RNA 2014; 20: 1431-1439.
29. Yu BH, Zhou Q, Wang ZL,. Periodontal ligament versus bone marrow mesenchymal stem cells in combination with Bio-Oss scaffolds for ectopic and in situ bone formation: A comparative study in the rat. J Biomater Appl 2014; 29: 243-253.
30. Lai RF, Li ZJ, Zhou ZY, et al., Effect of rhBMP-2 sustained-release nanocapsules on the ectopic osteogenesis process in Sprague-Dawley rats. Asian Pac J Trop Med 2013; 6: 884-888.
31. Ma SY, Feng ZQ, Lai RF, et al., Synergistic effect of RhBMP-2 and bFGF on ectopic osteogenesis in mice. Asian Pac J Trop Med 2015; 8: 53-59.
32. Kempen DH, Lu L, Hefferan TE, et al., Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. Tissue Eng Part A 2010; 16: 3769-3777.
33. Kang JS, Alliston T, Delston R, et al., Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J 2005; 24: 2543-2555.
34. Wapinski O, Chang HY,. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361.
35. Esteller M,. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
36. Zhu L, Xu PC,. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochem Biophys Res Commun 2013; 432: 612-617.
37. Wang KC, Yang YW, Liu B, et al., A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011; 472: 120-124.
38. Dey BK, Pfeifer K, Dutta A,. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev 2014; 28: 491-501.
39. Kallen AN, Zhou XB, Xu J, et al., The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-112.
40. Luo M, Li Z, Wang W, et al., Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213-221.
41. Hemming S, Cakouros D, Isenmann S, et al., EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 2014; 32: 802-815.
42. Chen YH, Yeh FL, Yeh SP, et al., Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. J Biol Chem 2011; 286: 10671-10680.
43. Zhu M, Chen Q, Liu X, et al., lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 2014; 281: 3766-3775.
44. James D, Levine AJ, Besser D, et al., TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005; 132: 1273-1282.
45. Bonewald LF, Dallas SL,. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 1994; 55: 350-357.
46. Centrella M, Horowitz MC, Wozney JM, et al., Transforming growth factor-beta gene family members and bone. Endocr Rev 1994; 15: 27-39.
47. Suzuki E, Ochiai-Shino H, Aoki H, et al., Akt activation is required for TGF-beta1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts. PLoS One 2014; 9: e112566.
48. Alliston T, Choy L, Ducy P, et al., TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001; 20: 2254-2272.
49. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584.
50. Kwak M, Hong S, Yu SL, et al., Parthenogenetic embryonic stem cells with H19 siRNA-mediated knockdown as a potential resource for cell therapy. Int J Mol Med 2012; 29: 257-262.